Detection of cryptic chromosomal lesions including acquired segmental uniparental disomy in advanced and low-risk myelodysplastic syndromes-Reference-Cited by-同舟云学术

Detection of cryptic chromosomal lesions including acquired segmental uniparental disomy in advanced and low-risk myelodysplastic syndromes

Published:2007-11 Issue:11 Volume:35 Page:1728-1738
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Gondek Lukasz P.,Haddad Abdo S.,O'Keefe Christine L.,Tiu Ramon,Wlodarski Marcin W.,Sekeres Mikkael A.,Theil Karl S.,Maciejewski Jaroslaw P.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference27 articles.

1. Monitoring treatment efficiency in MDS at the molecular level: possibilities now and in the future;van Dijk;Leuk Res,2004

2. Evaluation of clonality in myeloid stem-cell disorders;Gale;Semin Hematol,1999

3. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

4. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases;Morel;Leukemia,1993

5. Myelodysplastic syndromes;List;Hematology,2004

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in myelodysplastic syndromes;Annals of Medicine;2022-09-23

2. Genetics of progression from MDS to secondary leukemia;Blood;2020-07-02

3. Myelodysplastic Syndromes;Abeloff's Clinical Oncology;2020

4. Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic/myeloproliferative and myeloproliferative neoplasms;Cancer Genetics;2018-12

5. Identify latent chromosomal aberrations relevant to myelodysplastic syndromes;Scientific Reports;2017-09-04